SARS-CoV-2 virus — Drug Target
All drugs that target SARS-CoV-2 virus — marketed and clinical-stage. Includes 5 drug classes acting on this target.
Drug classes
vaccine · monoclonal antibody · mRNA vaccine · viral entry inhibitor · small molecule
Marketed (9)
- Comirnaty · Pfizer Inc. · vaccine · Infectious Disease
Comirnaty is an mRNA-based vaccine. - Famtozinameran 12 Years of age and older · Pfizer · monoclonal antibody · Infectious Disease
Famtozinameran works by targeting the SARS-CoV-2 virus. - BNT162b2 · Pfizer · vaccine · Immunology
- bivalent BNT162b2 (original/Omi BA.4/BA.5) · Pfizer · mRNA vaccine · Immunology
- Raxtozinameran 6 months to 4 years of age · Pfizer · viral entry inhibitor · Infectious Disease
- Low Dose PF-07328948 · Pfizer · small molecule · Infectious Disease
- Tozinameran 5 to 11 Years of age · Pfizer · vaccine · Immunology
- BNT162b2 BA.4/5 bivalent · Pfizer · mRNA vaccine · Immunology
- Combination (Bivalent) BNT162b2 and BNT162b2 OMI · Pfizer · vaccine · Immunology